546 related articles for article (PubMed ID: 25388618)
1. Comparison of a novel chemiluminescence enzyme immunoassay (CLEIA) with enzyme-linked immunosorbent assay (ELISA) for the determination of MPO-ANCA in patients with ANCA-associated vasculitis.
Hirose O; Itabashi M; Takei T; Nitta K
Mod Rheumatol; 2015 Mar; 25(2):230-4. PubMed ID: 25388618
[TBL] [Abstract][Full Text] [Related]
2. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
Zhang L; Shuai Z; Hu Z; Zhang M; Chen S
Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):511-6. PubMed ID: 26359012
[TBL] [Abstract][Full Text] [Related]
3. Two types of myeloperoxidase-antineutrophil cytoplasmic autoantibodies with a high affinity and a low affinity in small vessel vasculitis.
Yoshida M; Sasaki M; Nakabayashi I; Akashi M; Tomiyasu T; Yoshikawa N; Kojima T; Ohno N; Yamada M
Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S28-32. PubMed ID: 19646343
[TBL] [Abstract][Full Text] [Related]
4. Value of a new automated fluorescence immunoassay (EliA) for PR3 and MPO-ANCA in monitoring disease activity in ANCA-associated systemic vasculitis.
Sinico RA; Radice A; Corace C; DI Toma L; Sabadini E
Ann N Y Acad Sci; 2005 Jun; 1050():185-92. PubMed ID: 16014533
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of positive anti-neutrophil cytoplasmic antibodies without evidence of anti-neutrophil cytoplasmic antibodies-associated vasculitis.
Bornstein G; Ben-Zvi I; Furie N; Grossman C
Int J Rheum Dis; 2019 May; 22(5):940-945. PubMed ID: 30729688
[TBL] [Abstract][Full Text] [Related]
6. Clinical features of patients with anti-neutrophil cytoplasmic autoantibodies targeting native myeloperoxidase antigen.
Yamanishi Y; Ito-Ihara T; Nagao T; Uno K; Kobayashi S; Muso E; Shane PY; Firestein GS; Hashimoto H; Okazaki T; Suzuki K
Mod Rheumatol; 2013 Sep; 23(5):963-71. PubMed ID: 23085883
[TBL] [Abstract][Full Text] [Related]
7. [The clinical significance of circulating follicular helper T cells in patients with anti-neutrophil cytoplasmic myeloperoxidase antibody-associated vasculitis].
Wang S; Zheng MJ; Zhou XL; Liu YQ; Shuai ZW
Zhonghua Nei Ke Za Zhi; 2018 Oct; 57(10):738-742. PubMed ID: 30293334
[No Abstract] [Full Text] [Related]
8. Comparative analysis of different commercial ELISA systems for the detection of anti-neutrophil cytoplasm antibodies in ANCA-associated vasculitides.
Holle JU; Herrmann K; Gross WL; Csernok E
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S66-9. PubMed ID: 22512915
[TBL] [Abstract][Full Text] [Related]
9. The performance of the chemiluminescent immunoassay for measuring serum myeloperoxidase and proteinase 3 antibodies.
Hou X; Liu J; Wang T; Zhou J; Cui L
J Clin Lab Anal; 2021 Feb; 35(2):e23615. PubMed ID: 33034910
[TBL] [Abstract][Full Text] [Related]
10. Analytical and diagnostic accuracy of the EliA automated enzyme fluoroimmunoassay for antineutrophil cytoplasmic autoantibody detection.
Villalta D; Tonutti E; Tampoia M; Bizzaro N; Papisch W; Tozzoli R; Stella S
Clin Chem Lab Med; 2004; 42(10):1161-7. PubMed ID: 15552276
[TBL] [Abstract][Full Text] [Related]
11. Performance of two strategies for urgent ANCA and anti-GBM analysis in vasculitis.
de Joode AA; Roozendaal C; van der Leij MJ; Bungener LB; Sanders JS; Stegeman CA
Eur J Intern Med; 2014 Feb; 25(2):182-6. PubMed ID: 24361117
[TBL] [Abstract][Full Text] [Related]
12. [The significances of peripheral neutrophils CD(55) and myeloperoxidase expression in patients with myeloperoxidase-specific anti-neutrophil cytoplasmic antibody associated vasculitis].
Zhou XL; Zheng MJ; Shuai ZW; Zhang L; Zhang MM; Chen SY
Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):427-432. PubMed ID: 28592042
[No Abstract] [Full Text] [Related]
13. Follow-up of avidity and titer of anti-myeloperoxidase antibodies in sera from patients with primary ANCA-associated vasculitis.
Lin W; Chen M; Zhao MH
Autoimmunity; 2009 Mar; 42(3):198-202. PubMed ID: 19301200
[TBL] [Abstract][Full Text] [Related]
14. [Anti-neutrophil cytoplasmic antibody--enzyme immunosorbent assay].
Arimura Y; Marumo T; Fujii A; Nakabayashi K; Nagasawa T
Rinsho Byori; 2001 Jun; 49(6):571-4. PubMed ID: 11452543
[TBL] [Abstract][Full Text] [Related]
15. Epitope analysis of anti-myeloperoxidase antibodies in propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis.
Wang C; Gou SJ; Xu PC; Zhao MH; Chen M
Arthritis Res Ther; 2013; 15(6):R196. PubMed ID: 24252385
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.
Kim SM; Choi SY; Kim SY; Kim J
Rheumatol Int; 2019 Nov; 39(11):1919-1926. PubMed ID: 31552433
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.
Hagen EC; Daha MR; Hermans J; Andrassy K; Csernok E; Gaskin G; Lesavre P; Lüdemann J; Rasmussen N; Sinico RA; Wiik A; van der Woude FJ
Kidney Int; 1998 Mar; 53(3):743-53. PubMed ID: 9507222
[TBL] [Abstract][Full Text] [Related]
18. Verification, implementation and harmonization of automated chemiluminescent immunoassays for MPO- and PR3-ANCA detection.
Ogrič M; Švec T; Poljšak KM; Žigon P; Hočevar A; Čučnik S
Clin Chem Lab Med; 2024 Mar; 62(4):682-689. PubMed ID: 37870064
[TBL] [Abstract][Full Text] [Related]
19. Microparticles expressing myeloperoxidase as potential biomarkers in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV).
Manojlovic M; Juto A; Jonasdottir A; Colic J; Vojinovic J; Nordin A; Bruchfeld A; Gunnarsson I; Mobarrez F; Antovic A
J Mol Med (Berl); 2020 Sep; 98(9):1279-1286. PubMed ID: 32734361
[TBL] [Abstract][Full Text] [Related]
20. Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies associated vasculitis.
Gao Y; Ye H; Yu F; Guo XH; Zhao MH
Clin Immunol; 2005 Oct; 117(1):87-93. PubMed ID: 16019262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
